A new form of macrothrombocytopenia induced by a germ-line mutation in the PRKACG gene

Vladimir T Manchev1, Morgane Hilpert1, Eliane Berrou2

  • 1Institut National de la Santé et de la Recherche Médicale, Unité Mixte de Recherche 1009, Université Paris-Sud 11, Equipe Labellisée Ligue Contre le Cancer, Villejuif, France; University Paris Diderot, Paris, France; Gustave Roussy, Villejuif, France;

Blood
|July 26, 2014
PubMed

Insights

Inherited thrombocytopenias, specifically macrothrombocytopenias, can cause bleeding. A PRKACG gene mutation impairs platelet formation, leading to giant platelets and bleeding disorders.

Area of Science:

  • Hematology
  • Genetics
  • Molecular Biology

Background:

  • Macrothrombocytopenias are a heterogeneous group of inherited thrombocytopenias.
  • Affected genes regulate diverse cellular functions, including signaling, cytoskeleton organization, and gene expression.

Purpose of the Study:

  • To investigate the genetic basis of a severe autosomal recessive macrothrombocytopenia with thrombocytopathy in a consanguineous family.
  • To identify the specific gene and mutation responsible for the observed bleeding disorder.

Main Methods:

  • Clinical and hematological evaluation of affected family members.
  • Exome sequencing to identify causative mutations.
  • In vitro studies of megakaryocyte (MK) function, including proplatelet formation and filamin A levels.
  • Rescue experiments using lentiviral vectors to overexpress wild-type PRKACG.

Main Results:

  • A novel missense mutation (p.74Ile>Met) in the PRKACG gene was identified in homozygous patients.
  • This mutation cosegregated with the macrothrombocytopenia and bleeding tendency.
  • Homozygous patients exhibited impaired platelet activation, cytoskeleton reorganization, and markedly defective proplatelet formation.
  • Reduced filamin A levels were observed in patient MKs.
  • In vitro overexpression of wild-type PRKACG rescued the proplatelet formation defect.

Conclusions:

  • PRKACG is a newly identified gene involved in inherited thrombocytopenia with giant platelets.
  • The p.74Ile>Met PRKACG mutation disrupts platelet biogenesis, leading to macrothrombocytopenia and associated bleeding.
  • PRKACG plays a critical role in megakaryocyte proplatelet formation and platelet production.